Shionogi & Co., Ltd. (OTCMKTS:SGIOY) Releases Quarterly Earnings Results

Shionogi & Co., Ltd. (OTCMKTS:SGIOY) posted its quarterly earnings results on Friday. The company reported $0.16 earnings per share for the quarter, Zacks reports. Shionogi & Co., Ltd. had a net margin of 35.53% and a return on equity of 11.95%.

Shionogi & Co., Ltd. Stock Performance

SGIOY stock traded up $0.10 during mid-day trading on Friday, hitting $7.42. 98,808 shares of the company were exchanged, compared to its average volume of 218,618. The firm has a market cap of $12.62 billion, a P/E ratio of 12.65, a P/E/G ratio of 2.39 and a beta of 0.21. Shionogi & Co., Ltd. has a 1-year low of $6.22 and a 1-year high of $9.11. The firm’s 50 day simple moving average is $7.07 and its 200 day simple moving average is $8.59.

Shionogi & Co., Ltd. Company Profile

Shionogi & Co, Ltd. engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan. It offers Fetroja, a multidrug-resistant for gram-negative bacterial infection treatment; Cabenuva and Apretude an anti-HIV and HIV prophylactic drug; Xocova an oral COVID-19 treatment drug; Finibax a carbapenem antibiotic; Xofluza, an influenza antiviral drug; and Tivicay, an anti-HIV drug.